Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jul. 03, 2022
Jun. 30, 2021
Jul. 03, 2022
Jun. 30, 2021
Income Statement [Abstract]        
Revenue $ 5,101 $ 0 $ 5,101 $ 0
Cost of revenue 5,739 112 6,254 1,743
Gross margin (638) (112) (1,153) (1,743)
Operating expenses:        
Research and development 15,827 9,523 28,558 15,112
Selling, general and administrative 11,566 4,548 23,435 8,709
Total operating expenses 27,393 14,071 51,993 23,821
Loss from operations (28,031) (14,183) (53,146) (25,564)
Other income (expense):        
Change in fair value of convertible preferred stock warrants and common stock warrants 26,400 0 94,200 (4,781)
Interest expense, net 0 (135) 0 (135)
Other income (expense), net 496 15 518 12
Total other income (expense), net 26,896 (120) 94,718 (4,904)
Net income (loss) $ (1,135) $ (14,303) $ 41,572 $ (30,468)
Net income (loss) per share, basic (in dollars per share) $ (0.01) $ (0.15) $ 0.27 $ (0.32)
Weighted average number of common shares outstanding, basic (in shares) 152,521,389 97,433,726 152,082,655 96,629,530
Net income (loss) per share, diluted (in dollars per share) $ (0.18) $ (0.15) $ (0.34) $ (0.32)
Weighted average number of common shares outstanding, diluted (in shares) 152,521,389 97,433,726 152,924,803 96,629,530